Xencor (XNCR) Non Operating Income (2013 - 2026)

Xencor's (XNCR) quarterly Non Operating Income came in at -$50.8 million in Q1 2026, down 899.09% year-on-year from $6.4 million in Q1 2025, and down 202.86% on a QoQ basis from $49.4 million in Q4 2025.

Xencor (XNCR) Non Operating Income (2013 - 2026) Analysis & Trends

Xencor (XNCR) has 14 years of Non Operating Income data on file, last reported at -$50.8 million in Q1 2026.

  • On a quarterly basis, Non Operating Income fell 899.09% year-over-year to -$50.8 million in Q1 2026; TTM through Mar 2026 was $42.2 million, a 200.08% increase from a year earlier, with the FY2025 full-year figure at $87.9 million, up 255.48% from the prior year.
  • Non Operating Income for Q1 2026 stood at -$50.8 million, down from $49.4 million in the prior quarter.
  • Over the last five years, Non Operating Income for XNCR reached as high as $49.4 million in Q4 2025 and fell as low as -$50.8 million in Q1 2026.
  • Historically, Non Operating Income has averaged $1.3 million across 5 years, with a median of -$19000.0 in 2023.
  • Across the five-year window, Non Operating Income surged 502.07% in 2022 and sank 102284.21% in 2024, its largest moves.
  • Year by year, Non Operating Income stood at $30.1 million in 2022, then plunged by 46.63% to $16.1 million in 2023, then sank by 295.26% to -$31.4 million in 2024, then soared by 257.18% to $49.4 million in 2025, then tumbled by 202.86% to -$50.8 million in 2026.
  • Per Business Quant data, the three most recent Non Operating Income figures were -$50.8 million in Q1 2026, $49.4 million in Q4 2025, and $41.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -9.22 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 188.30 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - 5.75 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -8.59 Mn
10 Xencor 1.47 Bn 1.09 Bn - -50.77 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -50.77 Mn
Dec 31, 2025 49.36 Mn
Sep 30, 2025 41.49 Mn
Jun 30, 2025 2.10 Mn
Mar 31, 2025 -5.08 Mn
Dec 31, 2024 -31.41 Mn
Sep 30, 2024 7.76 Mn
Jun 30, 2024 -13.41 Mn
Mar 31, 2024 -19.45 Mn
Dec 31, 2023 16.08 Mn
Sep 30, 2023 -6.00 Mn
Jun 30, 2023 4.04 Mn
Mar 31, 2023 -19,000.00
Dec 31, 2022 30.14 Mn
Sep 30, 2022 6.68 Mn
Jun 30, 2022 -5.98 Mn
Mar 31, 2022 -2.87 Mn
Dec 31, 2021 -18.59 Mn
Sep 30, 2021 1.11 Mn
Jun 30, 2021 43.16 Mn